Are SGLT2 inhibitors effective against ‘all’ heart failure with preserved ejection fraction?

European Heart Journal - Cardiovascular Pharmacotherapy

28 January 2022
Organised by: Logo
ESC Journals

Contributors

Koji Hasegawa
Koji Hasegawa

Author

National Hospital Organization Kyoto Medical Centre Kyoto , Japan

ESC 365 is supported by